Prognostic analysis and mechanistic exploration of the autophagy-related exosome genes ITGA3, ITGB4, and PTK6 in pancreatic ductal adenocarcinoma
Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in mali...
Saved in:
Published in | Discover. Oncology Vol. 16; no. 1; pp. 1204 - 20 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.07.2025
Springer Nature B.V Springer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in malignant progression via bioinformatics analysis to provide a reference for the diagnosis, treatment and prognosis evaluation of PC, especially pancreatic ductal adenocarcinoma (PDAC). Matrix files of 178 PC tissues (including 143 PDAC) and 167 healthy human pancreatic tissues and clinical data were downloaded from the UCSC Xena database, exosome database (exoRbase) and autophagy database (HADb), and the relevant mechanisms were explored by bioinformatics methods, including differential analysis, LASSO regression analysis, survival analysis, functional analysis, immune infiltration analysis and drug sensitivity analysis. Finally, the expression of related genes in PDAC was verified via immunohistochemistry. Our research results indicate that the autophagy-related exosome genes PTK6, ITGA3 and ITGB4 are independent risk factors for PC and may promote PC development and invasion by promoting cell–cell adhesion and cell–matrix adhesion, inhibiting tumor cell autophagy, promoting nerve infiltration, reducing CD8 + T-cell content, and increasing M0 and M2 macrophage content. Drug susceptibility analysis showed that crizotinib, tamoxifen, ixazomib, and carboplatin had inhibitory effects on ITGA3, ITGB4, and PTK6. |
---|---|
AbstractList | Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in malignant progression via bioinformatics analysis to provide a reference for the diagnosis, treatment and prognosis evaluation of PC, especially pancreatic ductal adenocarcinoma (PDAC). Matrix files of 178 PC tissues (including 143 PDAC) and 167 healthy human pancreatic tissues and clinical data were downloaded from the UCSC Xena database, exosome database (exoRbase) and autophagy database (HADb), and the relevant mechanisms were explored by bioinformatics methods, including differential analysis, LASSO regression analysis, survival analysis, functional analysis, immune infiltration analysis and drug sensitivity analysis. Finally, the expression of related genes in PDAC was verified via immunohistochemistry. Our research results indicate that the autophagy-related exosome genes PTK6, ITGA3 and ITGB4 are independent risk factors for PC and may promote PC development and invasion by promoting cell-cell adhesion and cell-matrix adhesion, inhibiting tumor cell autophagy, promoting nerve infiltration, reducing CD8 + T-cell content, and increasing M0 and M2 macrophage content. Drug susceptibility analysis showed that crizotinib, tamoxifen, ixazomib, and carboplatin had inhibitory effects on ITGA3, ITGB4, and PTK6.Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in malignant progression via bioinformatics analysis to provide a reference for the diagnosis, treatment and prognosis evaluation of PC, especially pancreatic ductal adenocarcinoma (PDAC). Matrix files of 178 PC tissues (including 143 PDAC) and 167 healthy human pancreatic tissues and clinical data were downloaded from the UCSC Xena database, exosome database (exoRbase) and autophagy database (HADb), and the relevant mechanisms were explored by bioinformatics methods, including differential analysis, LASSO regression analysis, survival analysis, functional analysis, immune infiltration analysis and drug sensitivity analysis. Finally, the expression of related genes in PDAC was verified via immunohistochemistry. Our research results indicate that the autophagy-related exosome genes PTK6, ITGA3 and ITGB4 are independent risk factors for PC and may promote PC development and invasion by promoting cell-cell adhesion and cell-matrix adhesion, inhibiting tumor cell autophagy, promoting nerve infiltration, reducing CD8 + T-cell content, and increasing M0 and M2 macrophage content. Drug susceptibility analysis showed that crizotinib, tamoxifen, ixazomib, and carboplatin had inhibitory effects on ITGA3, ITGB4, and PTK6. Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in malignant progression via bioinformatics analysis to provide a reference for the diagnosis, treatment and prognosis evaluation of PC, especially pancreatic ductal adenocarcinoma (PDAC). Matrix files of 178 PC tissues (including 143 PDAC) and 167 healthy human pancreatic tissues and clinical data were downloaded from the UCSC Xena database, exosome database (exoRbase) and autophagy database (HADb), and the relevant mechanisms were explored by bioinformatics methods, including differential analysis, LASSO regression analysis, survival analysis, functional analysis, immune infiltration analysis and drug sensitivity analysis. Finally, the expression of related genes in PDAC was verified via immunohistochemistry. Our research results indicate that the autophagy-related exosome genes PTK6, ITGA3 and ITGB4 are independent risk factors for PC and may promote PC development and invasion by promoting cell–cell adhesion and cell–matrix adhesion, inhibiting tumor cell autophagy, promoting nerve infiltration, reducing CD8 + T-cell content, and increasing M0 and M2 macrophage content. Drug susceptibility analysis showed that crizotinib, tamoxifen, ixazomib, and carboplatin had inhibitory effects on ITGA3, ITGB4, and PTK6. Abstract Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis. This study aimed to screen autophagy-related exosome genes associated with poor prognosis in PC and to explore the underlying mechanisms in malignant progression via bioinformatics analysis to provide a reference for the diagnosis, treatment and prognosis evaluation of PC, especially pancreatic ductal adenocarcinoma (PDAC). Matrix files of 178 PC tissues (including 143 PDAC) and 167 healthy human pancreatic tissues and clinical data were downloaded from the UCSC Xena database, exosome database (exoRbase) and autophagy database (HADb), and the relevant mechanisms were explored by bioinformatics methods, including differential analysis, LASSO regression analysis, survival analysis, functional analysis, immune infiltration analysis and drug sensitivity analysis. Finally, the expression of related genes in PDAC was verified via immunohistochemistry. Our research results indicate that the autophagy-related exosome genes PTK6, ITGA3 and ITGB4 are independent risk factors for PC and may promote PC development and invasion by promoting cell–cell adhesion and cell–matrix adhesion, inhibiting tumor cell autophagy, promoting nerve infiltration, reducing CD8 + T-cell content, and increasing M0 and M2 macrophage content. Drug susceptibility analysis showed that crizotinib, tamoxifen, ixazomib, and carboplatin had inhibitory effects on ITGA3, ITGB4, and PTK6. |
ArticleNumber | 1204 |
Author | Guo, Pengcheng Xiao, Mingming Zu, Fuqiang Zhang, Chaochun Liu, Qingfeng Liang, Lunbing Hao, Guoliang |
Author_xml | – sequence: 1 givenname: Lunbing surname: Liang fullname: Liang, Lunbing organization: General Surgery, People’s Hospital of Liaoning Province, China Medical University – sequence: 2 givenname: Pengcheng surname: Guo fullname: Guo, Pengcheng organization: General Surgery, People’s Hospital of Liaoning Province, Dalian Medical University – sequence: 3 givenname: Mingming surname: Xiao fullname: Xiao, Mingming organization: The Pathology Department, People’s Hospital of Liaoning Province – sequence: 4 givenname: Fuqiang surname: Zu fullname: Zu, Fuqiang organization: Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Anhui Medical University – sequence: 5 givenname: Guoliang surname: Hao fullname: Hao, Guoliang organization: General Surgery, People’s Hospital of Liaoning Province, China Medical University – sequence: 6 givenname: Chaochun surname: Zhang fullname: Zhang, Chaochun organization: General Surgery, People’s Hospital of Liaoning Province, China Medical University – sequence: 7 givenname: Qingfeng surname: Liu fullname: Liu, Qingfeng email: drliuqf1970@126.com organization: General Surgery, JinQiu Hospital of LiaoNing Province |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40591082$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ksFu1DAQhiNUREvpC3BAkbhwaGBsJ05yQqWCsqISPSxna9aeZLNK7MVOEPsYfeN6N6W0HDjNyPP9v0ea_2VyZJ2lJHnN4D0DKD8ExmXJM-BFBgIky-Sz5ISXAjIJjB096o-TsxA2ABFlQkDxIjnOoagZVPwkub3xrrUujJ1O0WK_C12IjUkH0mu03WFAv7e98zh2zqauScc1pTiNbrvGdpd56nEkEyEX3EBpS5ZCulheXYjzffmUnx8Mb5bfZNrZdItWe8K9r5n0iH2KhqzT6HVn3YCvkucN9oHO7utp8uPL5-Xl1-z6-9Xi8uI603mdjxlDAzJHRiU3sqwZrpq8rKHCWghNrCmwMmCgqSVquarFCk0BpIsGKwlgjDhNFrOvcbhRW98N6HfKYacOD863Cn3csidVRHWV17JGzXNpsBJaasO5XrHclI2IXh9nr-20GshosqPH_onp04nt1qp1vxTjnOWcV9Hh3b2Ddz8nCqMauqCp79GSm4ISnEtRQFnlEX37D7pxk4-3mykoilqySL15vNLDLn9OHwE-A9q7EDw1DwgDtY-YmiOmYm7UIWJKRpGYRSHCtiX_9-__qO4ADwrUVQ |
Cites_doi | 10.2353/ajpath.2009.080811 10.1186/s13046-021-02059-6 10.1126/sciadv.aax7881 10.1016/j.jaci.2018.12.995 10.1093/nar/gkab1085 10.1038/s41586-020-2229-5 10.3389/fgene.2020.00705 10.1186/s13058-023-01720-6 10.3322/caac.21626 10.18632/oncotarget.27557 10.3390/pharmaceutics14102236 10.3322/caac.21763 10.3389/fonc.2021.658547 10.2147/IJN.S221383 10.1016/j.ymthe.2020.11.024 10.1016/j.arcmed.2020.09.009 10.1186/s13018-023-04338-8 10.1038/s41523-017-0047-1 10.1038/s41596-020-00466-1 10.1126/science.2821619 10.1002/med.21771 10.1038/sj.onc.1210508 10.1016/j.bbcan.2021.188592 10.1038/s41577-021-00537-8 10.1016/S0140-6736(16)00141-0 10.1002/jev2.12146 10.3322/caac.21654 10.3390/cells9041063 10.1053/j.gastro.2011.02.006 10.1038/nature15756 10.1002/adma.202002054 10.1146/annurev-immunol-042718-041717 10.2147/OTT.S197676 10.1016/j.xinn.2021.100141 10.1136/gutjnl-2019-319352 10.1158/0008-5472.CAN-15-3445 10.1038/cddis.2016.486 10.1146/annurev-immunol-101220-015603 10.1002/jmri.25952 10.1016/j.bbcan.2010.02.003 10.1053/j.gastro.2022.03.056 10.1007/s00253-018-9069-3 10.1038/s41467-017-01574-5 10.1016/j.bbrc.2018.05.062 10.3402/jev.v2i0.22097 10.1016/j.canlet.2021.03.010 10.1021/acs.molpharmaceut.9b00104 10.1007/s00281-019-00744-5 10.1016/j.jconrel.2019.07.021 10.1038/s41419-023-05590-w 10.1038/nrc2748 10.1038/cddiscovery.2015.36 10.1007/s00441-009-0834-6 10.1016/j.ygeno.2020.11.017 10.1186/s13045-022-01247-x 10.1056/NEJMra1404198 10.3748/wjg.v24.i43.4846 10.4161/auto.24870 10.1016/j.devcel.2019.04.011 10.1016/j.tcb.2014.12.006 10.1002/jcp.28472 10.1038/s41598-022-11050-w 10.1038/s41467-019-13665-6 10.1038/nmeth.3337 10.1186/s12951-022-01641-0 10.1038/s41392-021-00828-5 10.1074/jbc.M203877200 10.2147/IJN.S264498 10.1186/s12943-022-01671-0 10.7554/eLife.48963 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). Copyright Springer Nature B.V. Dec 2025 The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Springer Nature B.V. Dec 2025 – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1007/s12672-025-03061-6 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2730-6011 |
EndPage | 20 |
ExternalDocumentID | oai_doaj_org_article_53ba84969ac246da83c6cd22cb14d7f3 PMC12214228 40591082 10_1007_s12672_025_03061_6 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Department of Science and Technology of Liaoning Province grantid: 2021020370-JH2/103 funderid: https://doi.org/10.13039/501100012131 – fundername: Department of Science and Technology of Liaoning Province grantid: 2021020370-JH2/103 |
GroupedDBID | 0R~ 2JY 53G 7RV 7X7 8FI 8FJ AAJSJ AASML ABUWG AFBBN AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR C6C CCPQU EBS FYUFA GROUPED_DOAJ HMCUK NAPCQ PGMZT PHGZM PHGZT PIMPY RPM SOJ UKHRP AAYXX CITATION NPM PPXIY 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c494t-1ad064a1e72d6791abf47908a933ce1f5a8d0d0f96ac6b93bad50ec5fa8600dd3 |
IEDL.DBID | 7X7 |
ISSN | 2730-6011 |
IngestDate | Wed Aug 27 01:08:55 EDT 2025 Thu Aug 21 18:33:10 EDT 2025 Tue Aug 26 08:59:38 EDT 2025 Fri Jul 25 09:09:23 EDT 2025 Mon Jul 21 06:03:36 EDT 2025 Thu Jul 03 08:14:56 EDT 2025 Wed Jul 02 02:44:01 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Protein tyrosine kinase 6 Exosomes Autophagy Pancreatic cancer Integrins α3 Integrin β4 |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c494t-1ad064a1e72d6791abf47908a933ce1f5a8d0d0f96ac6b93bad50ec5fa8600dd3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3226055961?pq-origsite=%requestingapplication% |
PMID | 40591082 |
PQID | 3226055961 |
PQPubID | 5642930 |
PageCount | 20 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_53ba84969ac246da83c6cd22cb14d7f3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12214228 proquest_miscellaneous_3226350784 proquest_journals_3226055961 pubmed_primary_40591082 crossref_primary_10_1007_s12672_025_03061_6 springer_journals_10_1007_s12672_025_03061_6 |
PublicationCentury | 2000 |
PublicationDate | 2025-07-01 |
PublicationDateYYYYMMDD | 2025-07-01 |
PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Discover. Oncology |
PublicationTitleAbbrev | Discov Onc |
PublicationTitleAlternate | Discov Oncol |
PublicationYear | 2025 |
Publisher | Springer US Springer Nature B.V Springer |
Publisher_xml | – name: Springer US – name: Springer Nature B.V – name: Springer |
References | MC Bosco (3061_CR37) 2019; 143 SM Downs-Canner (3061_CR36) 2022; 40 K A (3061_CR30) 2007; 26 I Casari (3061_CR67) 2021; 507 AM Newman (3061_CR28) 2015; 12 K Ito (3061_CR44) 2016; 76 Y Xia (3061_CR40) 2020; 32 H Qiu (3061_CR42) 2002; 277 Y Li (3061_CR56) 2021; 11 W Zhang (3061_CR68) 2022; 20 R DU (3061_CR70) 2022; 14 QF Han (3061_CR13) 2022; 21 3061_CR21 3061_CR26 L Seguin (3061_CR54) 2015; 25 DP Ryan (3061_CR6) 2014; 371 AJ Grossberg (3061_CR5) 2020; 70 A Hoshino (3061_CR66) 2015; 527 A McGuigan (3061_CR1) 2018; 24 J Deng (3061_CR62) 2022; 12 K Yamamoto (3061_CR33) 2020; 581 Kdi Sa (3061_CR63) 2018; 501 AJ Harvey (3061_CR48) 2009; 175 XX Yang (3061_CR12) 2019; 308 C Meng (3061_CR24) 2023; 18 L You (3061_CR22) 2021; 41 Z Ren (3061_CR61) 2021; 113 C Liu (3061_CR43) 2021; 40 M Goggins (3061_CR7) 2020; 69 YD Lang (3061_CR47) 2019; 10 3061_CR2 R Crescitelli (3061_CR10) 2021; 16 JE Pullan (3061_CR69) 2019; 16 B Liu (3061_CR49) 2023; 14 E Ruoslahti (3061_CR53) 1987; 238 Y Zhang (3061_CR14) 2020; 15 LM Lindqvist (3061_CR16) 2015; 1 B Kulkarni (3061_CR25) 2020; 11 RL Siegel (3061_CR3) 2021; 71 C Liu (3061_CR8) 2018; 48 I Wortzel (3061_CR11) 2019; 49 M Kurachi (3061_CR35) 2019; 41 J Liu (3061_CR39) 2022; 15 H Liu (3061_CR58) 2019; 234 Y Yang (3061_CR38) 2021; 29 H Lai (3061_CR50) 2022; 50 N Chen (3061_CR57) 2013; 9 Y Jin (3061_CR60) 2020; 51 Y Ma (3061_CR23) 2019; 14 DJ Wozniak (3061_CR46) 2017; 8 M Barczyk (3061_CR55) 2010; 339 YH Tsang (3061_CR19) 2020; 9 K Görgülü (3061_CR15) 2020; 9 X Zhang (3061_CR18) 2018; 102 MZ Noman (3061_CR20) 2020; 6 A Wu (3061_CR52) 2020; 11 T Kamisawa (3061_CR9) 2016; 388 S Sakaguchi (3061_CR32) 2020; 38 T Wu (3061_CR27) 2021; 2 PM Brauer (3061_CR41) 2010; 1806 XR Tang (3061_CR64) 2017; 8 K Ito (3061_CR45) 2017; 3 Sshuo Wang (3061_CR59) 2019; 12 LD Wood (3061_CR4) 2022; 163 JS Desgrosellier (3061_CR51) 2010; 10 IV Bijnsdorp (3061_CR65) 2013; 2 Y Wang (3061_CR17) 2021; 1876 Y He (3061_CR29) 2021; 6 A Villanueva (3061_CR31) 2011; 140 M Reina-Campos (3061_CR34) 2021; 21 |
References_xml | – volume: 175 start-page: 1226 issue: 3 year: 2009 ident: 3061_CR48 publication-title: Am J Pathol doi: 10.2353/ajpath.2009.080811 – volume: 40 start-page: 297 issue: 1 year: 2021 ident: 3061_CR43 publication-title: Clin Cancer Res doi: 10.1186/s13046-021-02059-6 – volume: 6 start-page: eaax7881 issue: 18 year: 2020 ident: 3061_CR20 publication-title: Sci Adv doi: 10.1126/sciadv.aax7881 – volume: 143 start-page: 1348 issue: 4 year: 2019 ident: 3061_CR37 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2018.12.995 – volume: 50 start-page: D118 issue: D1 year: 2022 ident: 3061_CR50 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkab1085 – volume: 581 start-page: 100 issue: 7806 year: 2020 ident: 3061_CR33 publication-title: Nature doi: 10.1038/s41586-020-2229-5 – volume: 11 start-page: 705 year: 2020 ident: 3061_CR52 publication-title: Front Genet doi: 10.3389/fgene.2020.00705 – ident: 3061_CR26 doi: 10.1186/s13058-023-01720-6 – volume: 70 start-page: 375 issue: 5 year: 2020 ident: 3061_CR5 publication-title: CA Cancer J Clin doi: 10.3322/caac.21626 – volume: 11 start-page: 1832 issue: 20 year: 2020 ident: 3061_CR25 publication-title: Oncotarget doi: 10.18632/oncotarget.27557 – volume: 14 start-page: 2236 issue: 10 year: 2022 ident: 3061_CR70 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics14102236 – ident: 3061_CR2 doi: 10.3322/caac.21763 – volume: 11 start-page: 658547 year: 2021 ident: 3061_CR56 publication-title: Front Oncol doi: 10.3389/fonc.2021.658547 – volume: 14 start-page: 8121 year: 2019 ident: 3061_CR23 publication-title: Int J Nanomed doi: 10.2147/IJN.S221383 – volume: 29 start-page: 1226 issue: 3 year: 2021 ident: 3061_CR38 publication-title: Mol Ther doi: 10.1016/j.ymthe.2020.11.024 – volume: 51 start-page: 860 issue: 8 year: 2020 ident: 3061_CR60 publication-title: Arch Med Res doi: 10.1016/j.arcmed.2020.09.009 – volume: 18 start-page: 892 issue: 1 year: 2023 ident: 3061_CR24 publication-title: J Orthop Surg Res doi: 10.1186/s13018-023-04338-8 – volume: 3 start-page: 45 issue: 1 year: 2017 ident: 3061_CR45 publication-title: Npj Breast Cancer doi: 10.1038/s41523-017-0047-1 – volume: 16 start-page: 1548 issue: 3 year: 2021 ident: 3061_CR10 publication-title: Nat Protoc doi: 10.1038/s41596-020-00466-1 – volume: 238 start-page: 491 issue: 4826 year: 1987 ident: 3061_CR53 publication-title: Science doi: 10.1126/science.2821619 – volume: 41 start-page: 1622 issue: 3 year: 2021 ident: 3061_CR22 publication-title: Med Res Rev doi: 10.1002/med.21771 – volume: 26 start-page: 6979 issue: 49 year: 2007 ident: 3061_CR30 publication-title: Oncogene doi: 10.1038/sj.onc.1210508 – volume: 1876 start-page: 188592 issue: 2 year: 2021 ident: 3061_CR17 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbcan.2021.188592 – volume: 21 start-page: 718 issue: 11 year: 2021 ident: 3061_CR34 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00537-8 – volume: 388 start-page: 73 issue: 10039 year: 2016 ident: 3061_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(16)00141-0 – ident: 3061_CR21 doi: 10.1002/jev2.12146 – volume: 71 start-page: 7 issue: 1 year: 2021 ident: 3061_CR3 publication-title: CA Cancer J Clin doi: 10.3322/caac.21654 – volume: 9 start-page: 1063 issue: 4 year: 2020 ident: 3061_CR15 publication-title: Cells doi: 10.3390/cells9041063 – volume: 140 start-page: 1501 issue: 5 year: 2011 ident: 3061_CR31 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.02.006 – volume: 527 start-page: 329 issue: 7578 year: 2015 ident: 3061_CR66 publication-title: Nature doi: 10.1038/nature15756 – volume: 32 start-page: 2002054 issue: 40 year: 2020 ident: 3061_CR40 publication-title: Adv Mater doi: 10.1002/adma.202002054 – volume: 38 start-page: 541 year: 2020 ident: 3061_CR32 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-042718-041717 – volume: 12 start-page: 3695 year: 2019 ident: 3061_CR59 publication-title: OTT doi: 10.2147/OTT.S197676 – volume: 2 start-page: 100141 issue: 3 year: 2021 ident: 3061_CR27 publication-title: Innov doi: 10.1016/j.xinn.2021.100141 – volume: 69 start-page: 7 issue: 1 year: 2020 ident: 3061_CR7 publication-title: Gut doi: 10.1136/gutjnl-2019-319352 – volume: 76 start-page: 4406 issue: 15 year: 2016 ident: 3061_CR44 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-3445 – volume: 8 start-page: e2566 issue: 1 year: 2017 ident: 3061_CR64 publication-title: Cell Death Dis doi: 10.1038/cddis.2016.486 – volume: 40 start-page: 169 issue: 1 year: 2022 ident: 3061_CR36 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-101220-015603 – volume: 48 start-page: 382 issue: 2 year: 2018 ident: 3061_CR8 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.25952 – volume: 1806 start-page: 66 issue: 1 year: 2010 ident: 3061_CR41 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbcan.2010.02.003 – volume: 163 start-page: 386 issue: 2 year: 2022 ident: 3061_CR4 publication-title: Gastroenterology doi: 10.1053/j.gastro.2022.03.056 – volume: 102 start-page: 6503 issue: 15 year: 2018 ident: 3061_CR18 publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-018-9069-3 – volume: 8 start-page: 1508 issue: 1 year: 2017 ident: 3061_CR46 publication-title: Nat Commun doi: 10.1038/s41467-017-01574-5 – volume: 501 start-page: 758 issue: 3 year: 2018 ident: 3061_CR63 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.05.062 – volume: 2 start-page: 22097 issue: 1 year: 2013 ident: 3061_CR65 publication-title: J Extracell Vesicles doi: 10.3402/jev.v2i0.22097 – volume: 507 start-page: 124 year: 2021 ident: 3061_CR67 publication-title: Cancer Lett doi: 10.1016/j.canlet.2021.03.010 – volume: 16 start-page: 1789 issue: 5 year: 2019 ident: 3061_CR69 publication-title: Mol Pharm doi: 10.1021/acs.molpharmaceut.9b00104 – volume: 41 start-page: 327 issue: 3 year: 2019 ident: 3061_CR35 publication-title: Semin Immunopathol doi: 10.1007/s00281-019-00744-5 – volume: 308 start-page: 119 year: 2019 ident: 3061_CR12 publication-title: J Controlled Release doi: 10.1016/j.jconrel.2019.07.021 – volume: 14 start-page: 55 issue: 1 year: 2023 ident: 3061_CR49 publication-title: Cell Death Dis doi: 10.1038/s41419-023-05590-w – volume: 10 start-page: 9 issue: 1 year: 2010 ident: 3061_CR51 publication-title: Nat Rev Cancer doi: 10.1038/nrc2748 – volume: 1 start-page: 15036 issue: 1 year: 2015 ident: 3061_CR16 publication-title: Cell Death Discovery doi: 10.1038/cddiscovery.2015.36 – volume: 339 start-page: 269 issue: 1 year: 2010 ident: 3061_CR55 publication-title: Cell Tissue Res doi: 10.1007/s00441-009-0834-6 – volume: 113 start-page: 1166 issue: 1 year: 2021 ident: 3061_CR61 publication-title: Genomics doi: 10.1016/j.ygeno.2020.11.017 – volume: 15 start-page: 28 issue: 1 year: 2022 ident: 3061_CR39 publication-title: J Hematol Oncol doi: 10.1186/s13045-022-01247-x – volume: 371 start-page: 1039 issue: 11 year: 2014 ident: 3061_CR6 publication-title: N Engl J Med doi: 10.1056/NEJMra1404198 – volume: 24 start-page: 4846 issue: 43 year: 2018 ident: 3061_CR1 publication-title: WJG doi: 10.3748/wjg.v24.i43.4846 – volume: 9 start-page: 1214 issue: 8 year: 2013 ident: 3061_CR57 publication-title: Autophagy doi: 10.4161/auto.24870 – volume: 49 start-page: 347 issue: 3 year: 2019 ident: 3061_CR11 publication-title: Dev Cell doi: 10.1016/j.devcel.2019.04.011 – volume: 25 start-page: 234 issue: 4 year: 2015 ident: 3061_CR54 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2014.12.006 – volume: 234 start-page: 18382 issue: 10 year: 2019 ident: 3061_CR58 publication-title: J Cell Physiol doi: 10.1002/jcp.28472 – volume: 12 start-page: 7006 issue: 1 year: 2022 ident: 3061_CR62 publication-title: Sci Rep doi: 10.1038/s41598-022-11050-w – volume: 10 start-page: 5716 issue: 1 year: 2019 ident: 3061_CR47 publication-title: Nat Commun doi: 10.1038/s41467-019-13665-6 – volume: 12 start-page: 453 issue: 5 year: 2015 ident: 3061_CR28 publication-title: Nat Methods doi: 10.1038/nmeth.3337 – volume: 20 start-page: 446 issue: 1 year: 2022 ident: 3061_CR68 publication-title: J Nanobiotechnol doi: 10.1186/s12951-022-01641-0 – volume: 6 start-page: 425 issue: 1 year: 2021 ident: 3061_CR29 publication-title: Sig Transduct Target Ther doi: 10.1038/s41392-021-00828-5 – volume: 277 start-page: 34634 issue: 37 year: 2002 ident: 3061_CR42 publication-title: J Biol Chem doi: 10.1074/jbc.M203877200 – volume: 15 start-page: 6917 year: 2020 ident: 3061_CR14 publication-title: Int J Nanomed doi: 10.2147/IJN.S264498 – volume: 21 start-page: 207 issue: 1 year: 2022 ident: 3061_CR13 publication-title: Mol Cancer doi: 10.1186/s12943-022-01671-0 – volume: 9 start-page: e48963 year: 2020 ident: 3061_CR19 publication-title: eLife doi: 10.7554/eLife.48963 |
SSID | ssj0002513305 |
Score | 2.2959645 |
Snippet | Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve prognosis.... Abstract Pancreatic cancer (PC) is a highly malignant tumor with an extremely poor prognosis, but early diagnosis and treatment can significantly improve... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1204 |
SubjectTerms | Apoptosis Autophagy Biomarkers Breast cancer Cancer Research Exosomes Gene expression Immunotherapy Integrin β4 Integrins α3 Internal Medicine Medical prognosis Medicine Medicine & Public Health Metastasis Molecular Medicine Oncology Pancreatic cancer Protein tyrosine kinase 6 Proteins Radiotherapy Regression analysis Software Surgical Oncology Survival analysis Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICNxYy0cx3bsY4soBVTUw1bqLZrYTulhE7TdPfAz-MfMONltl4e4cEoUW9HI8_BneeYbxl4nCyrqFAQVMQptohXOaBBetlVHBF0yM96cfLHHZ_rTuTm_0eqLcsJGeuBx4d6aqgWnvfUQlLYRXBVsiEqFttSx7jLPJ-55Nw5TFIMVtS2RZqqSGWvllK2VoO6tBJNLYXd2okzY_yeU-Xuy5C83pnkjOrrH7k4Ikh-Mkt9nt1L_gN0-me7IH7Ifp8uBsudwmMNEOYIvkS8SVflmYmaecupd1gofOo4okMOaOAbg4rvI9S0p4qThalgkfkHxkH-cfzioZvQ41LP8w9P5Z8sve44BZcSegRN7LAoHGM1wk1yiRMMCHrGzo_fzd8diarwggvZ6JUqIiFSgTLWKtvYltJ2uvXTgqyqksjPgooyy8xaCbT1qKBqZgunAIX6KsXrM9vqhT08Z11Vdmq6WNcSgpda-DklCp40BQKwWC_Zmo4Tm28iv0VwzKZPKGlRZk1XW2IIdkp62M4kbO39Ai2kmi2n-ZTEF299ouZkc9qrBuIYHO-NtWbBX22F0Nbo_gT4N63FOhfjZ6YI9GY1iKwniXgReThXM7ZjLjqi7I_3l10znXSqivVOuYLONZV3L9fe1ePY_1uI5u6OyS1D-8T7bWy3X6QWirFX7MjvUT4DJI-s priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4k2gICNxYy0cv2If2xWlgIp62Eq9RRPbKT1sgvZx6M_oP2bsZLfaUg6cNlpPklHm4S_xzGdCPkYDIqjoWWpiZEoHw6xWwBxvZJsIunhmvDn5aY7P1PdzfT7S5KRemFvr95-XpTCVYGnT1YRuS2bukwe6lCZ58NRMt99TRNqohOuxL-buU3fmnkzRfxeu_Ls88tYaaZ56jp6QxyNmpAeDkZ-Se7F7Rh6ejKviz8n16aJP9XI4TGEkGcGDQOcx9fVmKmYac7FdtgPtW4q4j8I6sQrAxRXLHS0xoFC_7OeRXqQMSL_Nvh7ISfo5VJN8wdPZD0MvO4opZECbnia-WFQOMH_htLhAjfo5vCBnR19m02M2brXAvHJqxUoIiE2gjJUIpnIlNK2qHLfgpPSxbDXYwANvnQFvGicbCJpHr1uwiJhCkC_JXtd38TWhSlalbiteQfCKK-UqHzm0SmsARGehIJ82Rqh_D4wa9Q13cjJZjSars8lqU5DDZKetZGLDzn-gk9RjcNUa9bHKGQdeKBPASm98EMI3eL-qlQXZ31i5HkN0WWMmw1c57UxZkA_bYQyutGICXezXg4xExGxVQV4NTrHVBJEuQi0rCmJ33GVH1d2R7vJXJvAuRSK6E7Ygk41n3ej172fx5v_E35JHIjt_qi3eJ3urxTq-QwS1at7n0PkDF8YTvA priority: 102 providerName: Springer Nature |
Title | Prognostic analysis and mechanistic exploration of the autophagy-related exosome genes ITGA3, ITGB4, and PTK6 in pancreatic ductal adenocarcinoma |
URI | https://link.springer.com/article/10.1007/s12672-025-03061-6 https://www.ncbi.nlm.nih.gov/pubmed/40591082 https://www.proquest.com/docview/3226055961 https://www.proquest.com/docview/3226350784 https://pubmed.ncbi.nlm.nih.gov/PMC12214228 https://doaj.org/article/53ba84969ac246da83c6cd22cb14d7f3 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgV0JcEG8CS2UkbtQicfyIT2hb7bKAdlWhrtRb5NhO2UOTpY8DP4N_zIyTtiqvU5rYaqad8fjTeOYbQt4GZbkXwTEsYmRCesUKKSwzaZXXSNCVRsabyyt1cS0-z-SsD7it-rTKrU-Mjtq3DmPk78HwAHlLo7IPt98Zdo3C09W-hcZdcozUZZjSpWd6F2Ph2LwklX2tTFcxx5XmDHu4IljOmDrYjyJt_9-w5p8pk7-dm8bt6PwhedDjSHraKf4RuROax-TeZX9S_oT8nCxbzKGDYWp74hH44OkiYK1vpGemISbgRd3QtqaABandINOAnf9gscoleJjUrtpFoHP0ivTT9ONpPsTLSAzjF06mXxS9aSi4lQ6BOoocsiCcBZ8GW-USJGoX9im5Pj-bji9Y336BOWHEmmXWA16xWdDcK20yW9VCm7SwJs9dyGppC5_6tDbKOlWZvLJepsHJ2haAorzPn5Gjpm3CC0JFrjNZ61Rb70QqhNEupLYWUloLiM0n5N1WCeVtx7JR7vmUUWUlqKyMKitVQkaop91MZMiOD9rlvOwXXClBnkIYZazjQnlb5E45z7mr4H26zhNystVy2S_bVbk3soS82Q3DgsNTFNuEdtPNyQFFFyIhzzuj2EkC6BfgV8ETUhyYy4GohyPNzbdI6p1xJL_jRUKGW8vay_Xv_-Ll_3_GK3KfR2PH_OITcrRebsJrQFHrahCXyoAcj86uJl_hbqzGgxiRGMSQ1y8P8x9u |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwEB4tXQm4IN4EFjASnGhE4thOckBoC7u0dFtVqCvtLTi2U_bQZOlDaH8Gf4TfyNhJWpXXbU-JYiuZZMbjz_HMNwAvjZBUM6N8m8ToM66Fn3Am_TTIo8ISdAWO8WY0Fv1T9umMn-3BzzYXxoZVtj7ROWpdKfuP_A0aHiJvnorw3cU331aNsrurbQmN2iyG5vI7LtmWbwcfUL-vKD0-mr7v-01VAV-xlK38UGqchmVoYqpFnIYyL1icBonEpb0yYcFlogMdFKmQSuRplEvNA6N4IRMEB1pHeN9rsM8iXMp0YL93NJ583vzVobZcSsCb7Jw6R4-KmPq2aqyF56EvdmZAVyjgb-j2zyDN33Zq3QR4fBtuNciVHNamdgf2THkXro-avfl78GOyqGzUHjYT2VCd4Ikmc2Ozix0hNDEu5M9ZA6kKguiTyLXlNpCzS9_l1RiNnaplNTdkZv0wGUw_HkZde-ixrrvhZDoU5Lwk6MhqzKuIZa1F4SR6UZycFyhRNZf34fRKVPMAOmVVmkdAWBSHvIiDWGrFAsbSWJlAFoxzKREjag9et0rILmpej2zL4GxVlqHKMqeyTHjQs3ra9LSc3O5CtZhlzRDPOMqTsFSkUlEmtEwiJZSmVOX4vLiIPDhotZw1jmKZbc3agxebZhzidt9GlqZa130ixO0J8-BhbRQbSRBvI-BLqAfJjrnsiLrbUp5_dTTiIbV0ezTxoNta1lauf3-Lx_9_jedwoz8dnWQng_HwCdykzvBtdPMBdFaLtXmKGG6VP2sGDoEvVz1WfwHV7lpn |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEG8MBRYJTsSqvd6HfUCopYSG0CqHVMrNrHfXoYfYJQ-h_gz-Dr-OmbWdKLxuPdnyruxJ5rGfvTPfEPLKSc0sdybEIsaQCyvDVHAdZlGRlEjQFXnGm9MzeXLOP03EZIf87GphMK2yi4k-UNva4DfyAzA8QN4ik_FB2aZFjI777y6_hdhBCndau3YajYkM3dV3eH1bvB0cg65fM9b_MH5_ErYdBkLDM74MY21hSdaxU8xKlcW6KLnKolTDa75xcSl0aiMblZnURhZZUmgrImdEqVMACtYmcN8b5KZKRIw-piZq_X2HYeOUSLR1Ok21HpOKhdg_FoF6HMqttdC3DPgbzv0zXfO3PVu_FPbvkNsthqWHjdHdJTuuukf2Tttd-vvkx2heY_4eDFPdkp7AiaUzh3XGnhqaOp_85-2C1iUFHEr1ClkO9PQq9BU2zsKkelHPHJ1iRKaD8cfDpIeHI97zNxyNh5JeVBRCWoN-DUX-WhBOQzyFZXoOEtUz_YCcX4tiHpLdqq7cY0J5omJRqkhpa3jEeaaMi3TJhdAa0KINyJtOCfllw_CRb7icUWU5qCz3KstlQI5QT-uZyM7tL9Tzad46ey5AnpRnMtOGcWl1mhhpLGOmgOepMgnIfqflvA0Zi3xj4AF5uR4GZ8cdHF25etXMSQDBpzwgjxqjWEsCyBugX8oCkm6Zy5ao2yPVxVdPKB4zJN5jaUB6nWVt5Pr3f_Hk_z_jBdkDD80_D86GT8kt5u0e05z3ye5yvnLPAMwti-feayj5ct1u-gsHc103 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+analysis+and+mechanistic+exploration+of+the+autophagy-related+exosome+genes+ITGA3%2C+ITGB4%2C+and+PTK6+in+pancreatic+ductal+adenocarcinoma&rft.jtitle=Discover.+Oncology&rft.au=Liang%2C+Lunbing&rft.au=Guo%2C+Pengcheng&rft.au=Xiao%2C+Mingming&rft.au=Zu%2C+Fuqiang&rft.date=2025-07-01&rft.eissn=2730-6011&rft.volume=16&rft.issue=1&rft.spage=1204&rft_id=info:doi/10.1007%2Fs12672-025-03061-6&rft_id=info%3Apmid%2F40591082&rft.externalDocID=40591082 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2730-6011&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2730-6011&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2730-6011&client=summon |